Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

ClinicalTrials.gov ID: NCT00570986

Public ClinicalTrials.gov record NCT00570986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 6:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety and efficacy of 2 doses of ABT-874 versus placebo in the treatment of subjects with moderate to severe plaque psoriasis.

Study identification

NCT ID
NCT00570986
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Enrollment
1,465 participants

Conditions and interventions

Interventions

Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2007 (Type not available)
Primary completion
Jun 2009 (Actual)
Completion
Jun 2009 (Actual)
Last update posted
Feb 8, 2013

2007 – 2009

United States locations

U.S. sites
93
U.S. states
32
U.S. cities
79
Facility City State ZIP Site status
Site Reference ID/Investigator# 6579 Birmingham Alabama 35205 —
Site Reference ID/Investigator# 6697 Birmingham Alabama 35233 —
Site Reference ID/Investigator# 7015 Huntsville Alabama 35801 —
Site Reference ID/Investigator# 6728 Scottsdale Arizona 85251 —
Site Reference ID/Investigator# 6584 Tucson Arizona 85710 —
Site Reference ID/Investigator# 6696 Little Rock Arkansas 72205 —
Site Reference ID/Investigator# 6591 Bakersfield California 93309 —
Site Reference ID/Investigator# 6710 Fresno California 93720 —
Site Reference ID/Investigator# 7885 Irvine California 92697 —
Site Reference ID/Investigator# 6872 Los Angeles California 90045 —
Site Reference ID/Investigator# 7669 Oceanside California 92056 —
Site Reference ID/Investigator# 6821 San Diego California 92103 —
Site Reference ID/Investigator# 6832 San Diego California 92117 —
Site Reference ID/Investigator# 7305 San Diego California 92123 —
Site Reference ID/Investigator# 7990 San Francisco California 94118 —
Site Reference ID/Investigator# 6711 Santa Monica California 90404 —
Site Reference ID/Investigator# 8139 Torrance California 90503 —
Site Reference ID/Investigator# 7167 Vallejo California 94589 —
Site Reference ID/Investigator# 7302 Denver Colorado 80209 —
Site Reference ID/Investigator# 6921 Longmont Colorado 80501 —
Site Reference ID/Investigator# 6917 New Haven Connecticut 06511 —
Site Reference ID/Investigator# 6707 Jacksonville Florida 32204 —
Site Reference ID/Investigator# 7301 Miami Florida 33136 —
Site Reference ID/Investigator# 7012 Miami Florida 33144 —
Site Reference ID/Investigator# 6831 Miami Florida 33173 —
Site Reference ID/Investigator# 7016 South Miami Florida 33143 —
Site Reference ID/Investigator# 6590 West Palm Beach Florida 33407 —
Site Reference ID/Investigator# 6582 Alpharetta Georgia 30022 —
Site Reference ID/Investigator# 7450 Atlanta Georgia 30327 —
Site Reference ID/Investigator# 6714 Newnan Georgia 30263 —
Site Reference ID/Investigator# 6717 Snellville Georgia 30078 —
Site Reference ID/Investigator# 7017 Arlington Heights Illinois 60005 —
Site Reference ID/Investigator# 7877 Maywood Illinois 60153 —
Site Reference ID/Investigator# 6704 Skokie Illinois 60077 —
Site Reference ID/Investigator# 7292 West Dundee Illinois 60118 —
Site Reference ID/Investigator# 6706 Indianapolis Indiana 46256 —
Site Reference ID/Investigator# 7646 Indianapolis Indiana 46260 —
Site Reference ID/Investigator# 7014 Overland Park Kansas 66202 —
Site Reference ID/Investigator# 6873 Louisville Kentucky 40202 —
Site Reference ID/Investigator# 7523 Owensboro Kentucky 42303 —
Site Reference ID/Investigator# 6597 Andover Massachusetts 01810 —
Site Reference ID/Investigator# 6703 Boston Massachusetts 02111 —
Site Reference ID/Investigator# 7644 Detroit Michigan 48202 —
Site Reference ID/Investigator# 6826 Fort Gratiot Michigan 48059 —
Site Reference ID/Investigator# 7989 Grand Blanc Michigan 48439 —
Site Reference ID/Investigator# 6581 Fridley Minnesota 55432 —
Site Reference ID/Investigator# 7890 St Louis Missouri 63110 —
Site Reference ID/Investigator# 6709 St Louis Missouri 63117 —
Site Reference ID/Investigator# 7451 Omaha Nebraska 68144 —
Site Reference ID/Investigator# 7299 Berlin New Jersey 08009 —
Site Reference ID/Investigator# 6924 East Windsor New Jersey 08520 —
Site Reference ID/Investigator# 6577 New Brunswick New Jersey 08903 —
Site Reference ID/Investigator# 7030 Albuquerque New Mexico 87106 —
Site Reference ID/Investigator# 7878 Buffalo New York 14221 —
Site Reference ID/Investigator# 7876 New York New York 10016 —
Site Reference ID/Investigator# 6599 New York New York 10025 —
Site Reference ID/Investigator# 6895 New York New York 10029-6501 —
Site Reference ID/Investigator# 7637 New York New York 10032 —
Site Reference ID/Investigator# 7504 Rochester New York 14623 —
Site Reference ID/Investigator# 7018 Stoney Brook New York 11790 —
Site Reference ID/Investigator# 6926 Hickory North Carolina 28601 —
Site Reference ID/Investigator# 7293 Wilmington North Carolina 28401 —
Site Reference ID/Investigator# 8251 Winston-Salem North Carolina 27157 —
Site Reference ID/Investigator# 6598 Cincinnati Ohio 45219 —
Site Reference ID/Investigator# 8082 Cleveland Ohio 44106 —
Site Reference ID/Investigator# 7165 Columbus Ohio 43212 —
Site Reference ID/Investigator# 7659 Dayton Ohio 45408 —
Site Reference ID/Investigator# 6727 Lake Oswego Oregon 97035 —
Site Reference ID/Investigator# 6894 Portland Oregon 97210 —
Site Reference ID/Investigator# 6578 Portland Oregon 97223 —
Site Reference ID/Investigator# 7295 Portland Oregon 97239 —
Site Reference ID/Investigator# 7879 Hershey Pennsylvania 17033 —
Site Reference ID/Investigator# 6712 Philadelphia Pennsylvania 19103 —
Site Reference ID/Investigator# 6580 Johnston Rhode Island 02919 —
Site Reference ID/Investigator# 6576 Providence Rhode Island 02903 —
Site Reference ID/Investigator# 6589 Greer South Carolina 29651 —
Site Reference ID/Investigator# 6586 Goodlettsville Tennessee 37072 —
Site Reference ID/Investigator# 7668 Knoxville Tennessee 37934 —
Site Reference ID/Investigator# 6915 Nashville Tennessee 37215 —
Site Reference ID/Investigator# 6825 Arlington Texas 76011 —
Site Reference ID/Investigator# 6762 Austin Texas 78759 —
Site Reference ID/Investigator# 6822 Dallas Texas 75230 —
Site Reference ID/Investigator# 7671 Dallas Texas 75246-1613 —
Site Reference ID/Investigator# 6705 Houston Texas 77030 —
Site Reference ID/Investigator# 6708 San Antonio Texas 78229 —
Site Reference ID/Investigator# 7081 San Antonio Texas 78229 —
Site Reference ID/Investigator# 6912 Tyler Texas 75703 —
Site Reference ID/Investigator# 7306 Webster Texas 77598 —
Site Reference ID/Investigator# 8101 Salt Lake City Utah 84132 —
Site Reference ID/Investigator# 6807 Norfolk Virginia 23507 —
Site Reference ID/Investigator# 6801 Seattle Washington 98101 —
Site Reference ID/Investigator# 7519 Spokane Washington 99204 —
Site Reference ID/Investigator# 7080 Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00570986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2013 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00570986 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →